Simplex Trading
PVLA

Simplex Trading’s Palvella Therapeutics PVLA Stock Holding History

Simplex Trading’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Buy
2,218
+596
+37% +$72.3K ﹤0.01% 4085
2026
Q1 		$202K Buy
+1,622
New +$169K ﹤0.01% 4282
2023
Q1 		– Sell
-6
Closed -$695 – 10337
2022
Q4 		$0 Hold
6
– – ﹤0.01% 10684
2022
Q3 		$0 Sell
6
-76
-93% -$9.8K ﹤0.01% 11072
2022
Q2 		$12K Buy
+82
New +$15K ﹤0.01% 8157
2022
Q1 		– Sell
-9
Closed -$2.37K – 11576
2021
Q4 		$2K Sell
9
-502
-98% -$161K ﹤0.01% 10086
2021
Q3 		$157K Hold
511
– – ﹤0.01% 5983
2021
Q2 		$156K Buy
+511
New +$112K ﹤0.01% 6083
2020
Q4 		– Sell
-43
Closed -$7K – 9217
2020
Q3 		$7K Buy
43
+39
+975% +$8.88K ﹤0.01% 6983
2020
Q2 		$0 Buy
+4
New +$935 ﹤0.01% 8525
2019
Q4 		– Sell
-180
Closed -$49.9K – 8092
2019
Q3 		$49K Buy
180
+175
+3,500% +$67.8K ﹤0.01% 5042
2019
Q2 		$1K Buy
+5
New +$1.49K ﹤0.01% 6923
2018
Q2 		– Sell
-1
Closed – – 7981
2018
Q1 		$0 Buy
+1
New +$619 ﹤0.01% 7006

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Simplex Trading's PVLA Position: Q2 2026 in Review

Simplex Trading increased its Palvella Therapeutics (PVLA) stake by 37% in Q2 2026, buying an estimated $72.3K and bringing the position to 2,218 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #4085.

Simplex Trading first reported a position in PVLA in Q1 2018 and has held it in 13 quarters since. 196 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Simplex Trading held 2,218 shares of Palvella Therapeutics worth $339K as of Q2 2026.
  • Simplex Trading bought 596 Palvella Therapeutics shares in Q2 2026, an estimated $72.3K.
  • Palvella Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4085 holding.
  • Simplex Trading first reported a position in Palvella Therapeutics in Q1 2018 and has held it in 13 quarters since.
  • 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.